The Global Health Innovative Technology Fund (GHIT Fund), along with the New York Academy of Sciences and Japan Society, will host a panel discussion – comprised of preeminent global health experts – to examine recent successes and setbacks in global health and what they see as the secret ingredient to moving a vaccine, cure or diagnostic across the finish line and into the field.
Panelists will provide their unique perspectives on:
The discussion will include an opportunity for questions from attendees. A networking reception will follow the panel.
November 12, 2013
333 East 47th Street
New York, NY 10017
For more information on this event, please visit http://bit.ly/GHITEvent or email firstname.lastname@example.org.
About the Global Health Innovative Technology Fund
The Global Health Innovative Technology Fund is a non-profit organization aimed at mobilizing Japanese R&D for global health. A public-private partnership between the Government of Japan, a consortium of Japanese pharmaceutical companies, and the Bill & Melinda Gates Foundation, the GHIT Fund seeks to develop new drugs, vaccines and diagnostics for infectious diseases prevalent in developing countries. More information is available at http://www.ghitfund.org.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.